Skip to content
10-Q

Quarterly Report

AMEXDRUG CORP

0001096906-13-000915

← back to feed
Filed
May 20, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2013 · May 14, 2013 169.41M sh
Stock Repurchased Q1 2013 · Mar 31, 2013 $1.24K
Stock Repurchased Q1 2013 · Mar 31, 2012 $947
Capex Q1 2013 · Mar 31, 2013 $2.4K
Operating Cash Flow Q1 2013 · Mar 31, 2013 −$158.98K
Operating Cash Flow Q1 2013 · Mar 31, 2012 −$6.69K
Cash And Equivalents Q1 2013 · Mar 31, 2013 $125.97K
Cash And Equivalents Q1 2013 · Dec 31, 2012 $415.96K
Cash And Equivalents Q1 2013 · Mar 31, 2012 $127.71K
Stockholders Equity Q1 2013 · Mar 31, 2013 $600.76K
Stockholders Equity Q1 2013 · Dec 31, 2012 $429.65K
Current Liabilities Q1 2013 · Mar 31, 2013 $1.22M
Current Liabilities Q1 2013 · Dec 31, 2012 $1.64M
Total Liabilities Q1 2013 · Mar 31, 2013 $1.54M
Total Liabilities Q1 2013 · Dec 31, 2012 $1.98M
Current Assets Q1 2013 · Mar 31, 2013 $1.62M
Current Assets Q1 2013 · Dec 31, 2012 $1.87M
Total Assets Q1 2013 · Mar 31, 2013 $2.14M
Total Assets Q1 2013 · Dec 31, 2012 $2.41M
Sga Expense Q1 2013 · Mar 31, 2013 $243.21K
Sga Expense Q1 2013 · Mar 31, 2012 $188.84K
Net Income Q1 2013 · Mar 31, 2013 $172.35K
Net Income Q1 2013 · Mar 31, 2012 $104.09K
Operating Income Q1 2013 · Mar 31, 2013 $257.86K
Operating Income Q1 2013 · Mar 31, 2012 $169.33K
Gross Profit Q1 2013 · Mar 31, 2013 $518.75K
Gross Profit Q1 2013 · Mar 31, 2012 $360.64K
Cost Of Revenue Q1 2013 · Mar 31, 2013 $1.84M
Cost Of Revenue Q1 2013 · Mar 31, 2012 $1.82M
Revenue Q1 2013 · Mar 31, 2013 $2.36M
Revenue Q1 2013 · Mar 31, 2012 $2.18M